Chemoinformaics analysis of 2,6,6-TRIMETHYL-2-VINYLTETRAHYDROPYRAN
| Molecular Weight | 154.253 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
| Exact Molecular Weight | 154.136 | nRing | 1 |
| Solubility: LogS | -2.283 | nHRing | 1 |
| Solubility: LogP | 2.735 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 0 | BPOL | 19.7937 |
| QED | 0.528 |
| Synth | 3.783 |
| Natural Product Likeliness | 2.574 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.319 |
| MDCK | 0.0000197 |
| BBB | 0.395 |
| PPB | 0.850618 |
| VDSS | 1.355 |
| FU | 0.214548 |
| CYP1A2-inh | 0.086 |
| CYP1A2-sub | 0.817 |
| CYP2c19-inh | 0.249 |
| CYP2c19-sub | 0.928 |
| CYP2c9-inh | 0.076 |
| CYP2c9-sub | 0.653 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.772 |
| CYP3a4-inh | 0.452 |
| CYP3a4-sub | 0.396 |
| CL | 6.932 |
| T12 | 0.555 |
| hERG | 0.013 |
| Ames | 0.01 |
| ROA | 0.032 |
| SkinSen | 0.219 |
| Carcinogencity | 0.342 |
| EI | 0.976 |
| Respiratory | 0.14 |
| NR-Aromatase | 0.034 |
| Antiviral | No |
| Prediction | 0.926017 |